Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
94 studies found for:    Open Studies | "Adrenal Gland Diseases"
Show Display Options
Rank Status Study
21 Recruiting Adrenocortical Functions in Women With Nonclassical 21-hydroxylase Deficiency.
Conditions: Adrenal Hyperplasia, Congenital;   21-hydroxylase Deficiency
Intervention: Other: Functional explorations
22 Unknown  Metabolic Syndrome and Insulin Resistance in Primary Aldosteronism
Condition: Primary Aldosteronism
Intervention: Procedure: Glucose tolerance test
23 Recruiting Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly
Conditions: Cushing's Disease,;   Acromegaly
Interventions: Drug: Pasireotide s.c.;   Drug: Sitagliptin;   Drug: Liraglutide;   Drug: Insulin;   Drug: Pasireotide LAR;   Drug: Metformin
24 Recruiting Decision Support for Parents Receiving Information About Child's Rare Disease
Conditions: Disorder of Sex Development;   Intersex Conditions;   Congenital Adrenal Hyperplasia;   Hypospadias
Intervention: Behavioral: Decision Support Tool
25 Recruiting Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders
Conditions: Mucopolysaccharidosis;   Hurler Syndrome;   Hunter Syndrome;   Maroteaux-Lamy Syndrome;   Sly Syndrome;   Alpha Mannosidosis;   Fucosidosis;   Aspartylglucosaminuria;   Adrenoleukodystrophy (ALD);   Krabbe Disease;   Metachromatic Leukodystrophy (MLD);   Sphingolipidoses;   Peroxisomal Disorders
Interventions: Drug: Campath-1H;   Drug: Cyclophosphamide;   Drug: Busulfan;   Procedure: Allogeneic stem cell transplantation;   Drug: Cyclosporine A;   Drug: Mycophenolate Mofetil
26 Recruiting Influence of Synacthen Infusion on the Results of Adrenal Venous Sampling in Patient With Primary Aldosteronism
Condition: Primary Aldosteronism
Intervention: Drug: Synacthen infusion during adrenal venous sampling
27 Recruiting HSCT for High Risk Inherited Inborn Errors
Conditions: Adrenoleukodystrophy;   Metachromatic Leukodystrophy;   Globoid Cell Leukodystrophy;   Tay Sachs Disease;   Sandhoffs Disease;   Wolman Disease;   I-Cell Disease;   Sanfilippo Syndrome;   GM1 Gangliosidosis
Interventions: Drug: Clofarabine;   Procedure: Total body Irradiation;   Drug: Melphalan;   Biological: Hematopoietic Stem Cell Transplantation;   Drug: Alemtuzumab;   Drug: mycophenylate mofetil;   Device: Cyclosporine A;   Drug: Hydroxyurea
28 Unknown  Mutation Analysis of 17α-Hydroxylase
Conditions: Pseudohermaphroditism;   Congenital Adrenal Hyperplasia;   Hypertension
Intervention: Procedure: blood drawing
29 Not yet recruiting Ultradian Subcutaneous Hydrocortisone Infusion in Addison Disease
Condition: Addison Disease
Interventions: Drug: Solu-Cortef;   Drug: Cortef
30 Unknown  Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer Patients
Condition: Adrenocortical Carcinoma
Interventions: Drug: Sorafenib;   Drug: Paclitaxel
31 Recruiting Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome
Conditions: Prader Willi Syndrome;   Adrenal Insufficiency
Interventions: Other: Low dose (1 mcg) ACTH stimulation test;   Other: Overnight metyrapone test
32 Unknown  The Effects of Case Management in a Medicaid Managed Care Plan
Conditions: Neoplasms;   Heart Diseases;   Adrenal Cortex Diseases
Intervention: Behavioral: Case management
33 Unknown  Does Aldosterone Cause Hypertension by a Non-Renal Mechanism?
Conditions: Hypertension;   Dialysis;   Hyperaldosteronism
Interventions: Drug: Eplerenone;   Drug: Placebo
34 Recruiting Study of Adrenal Gland Tumors
Condition: Adrenal Gland Neoplasm
Intervention:
35 Unknown  German Adrenocortical Carcinoma Registry
Condition: Adrenocortical Carcinoma
Intervention:
36 Recruiting Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
Condition: Cushing's Disease
Intervention: Drug: LCI699
37 Unknown  Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer
Condition: Adrenocortical Carcinoma
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
38 Recruiting Surgery and Heated Chemotherapy for Adrenocortical Carcinoma
Conditions: Adrenocortical Carcinoma;   Peritoneal Carcinomatosis
Interventions: Drug: Cisplatin;   Procedure: Cytoreductive surgery
39 Recruiting The Effect of Disease-specific Treatment on Bone Turnover Markers in Patients With Primary Aldosteronism
Condition: Primary Aldosteronism
Intervention:
40 Unknown  Evaluation of Side Effects of Mitotane
Condition: Adrenocortical Carcinoma
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years